Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...
Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...
Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for ...
GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
This week, odd new details emerge as authorities continue to investigate the New Year's Day Tesla Cybertruck explosion in Las ...
The slimmed-down star is just one of the celebs who have embraced wood therapy massages to help break down fat and cellulite.